WO2016026614A1 - Préparation cosmétique stable - Google Patents

Préparation cosmétique stable Download PDF

Info

Publication number
WO2016026614A1
WO2016026614A1 PCT/EP2015/066019 EP2015066019W WO2016026614A1 WO 2016026614 A1 WO2016026614 A1 WO 2016026614A1 EP 2015066019 W EP2015066019 W EP 2015066019W WO 2016026614 A1 WO2016026614 A1 WO 2016026614A1
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
ethylhexyl
cosmetic
triazine
acid
Prior art date
Application number
PCT/EP2015/066019
Other languages
German (de)
English (en)
Inventor
Anja Eitrich
Sabine FÄNGER
Bente Nissen
Katharina Reiter
Sarah Sprock
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Priority to EP15739232.5A priority Critical patent/EP3182954A1/fr
Publication of WO2016026614A1 publication Critical patent/WO2016026614A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Definitions

  • the present invention relates to an oil-in-water cosmetic emulsion (O / W emulsion) or aqueous external phase hydrodispersion containing glycine which is free of
  • UVB and UVA radiation (wavelength: 320-400 nm) also leads to a weakening of the elastic and collagen fibers of the connective tissue. This leads to numerous
  • UVA and UVB filters are in the form of positive lists in most industrialized countries such as Appendix 7 of the
  • a low-viscosity, sprayable cosmetic preparation in particular an emulsion or
  • the objects are achieved by a cosmetic oil-in-water emulsion (O / W emulsion) or hydrodispersion with external aqueous phase containing glycine, wherein the preparation is free of zinc compounds.
  • Zinc compounds according to the invention are understood to mean zinc salts (in particular zinc sulfate) and zinc oxides.
  • cosmetic preparation is understood as meaning both a cosmetic oil-in-water emulsion (O / W emulsion) and a hydrous dispersion with an external aqueous phase Make-up or used as a sunscreen.
  • particularly advantageous embodiments of the present invention are characterized in that the preparation contains 2,4-bis - ⁇ [4- (2-ethylhexyloxy) -2-hydroxy] - phenyl ⁇ -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI bis-ethylhexyloxyphenol methoxyphenyl triazines).
  • the preparation contains 2,4-bis - ⁇ [4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl ⁇ -6- (4-methoxyphenyl) -1,3, 5-triazine (INCI bis-ethylhexyloxyphenol methoxyphenyl triazines) in a concentration of 0.1 to 5% by weight, based on the total weight of the preparation contains.
  • the preparation comprises 2,4-bis - ⁇ [4- (2-ethylhexyloxy) -2-hydroxy] -phenyl ⁇ -6- (4-methoxyphenyl) -1,33- triazine (INCI bis-ethylhexyloxyphenol methoxyphenyl triazines) in a concentration of 1 to 4% by weight, based on the total weight of the preparation contains.
  • the cosmetic preparation according to the invention is characterized in that the preparation contains one or more UV filters, which are selected from the group of compounds 2-phenylbenzimidazole-5-sulfonic acid and / or salts thereof; Phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bomylidenemethyl) benzene and its salts; 4- (2-oxo-3-bomylidenemethyl) benzenesulfonic acid salts; 2-methyl-5- (2-oxo-3-bomylidenemethyl) sulfonic acid salts; 2,2'-methylene-bis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); 2- (2H-Benzotriazol-2-yl) -4-methyl
  • ethylhexyl salicylate Terephthalidendicamphersulfonkla; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate; 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester; 4- (dimethylamino) benzoic acid amyl ester; 4-Methoxybenzalmalon-klaredi (2-ethylhexyl) ester; 2-ethylhexyl 4-methoxycinnamate; Isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone;
  • Dioctylbutylamidotriazone (INCI: diethylhexyl-butamidotriazone); 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine with the CAS No.
  • the preparation according to the invention is particularly preferably free from 3- (4-methylbenzylidene) camphor and 2-hydroxy-4-methoxybenzophenone (oxybenzone).
  • a preferred embodiment of the present invention according to the invention is characterized in that the preparation is in the form of an O / W emulsion containing one or more emulsifiers selected from the group consisting of glyceryl stearate citrate,
  • Cetearyl alcohol sodium cetearyl sulfate, glyceryl stearate, cetearyl sulfosuccinate, ceteareth-20, sodium stearoyl glutamate, polyglyceryl-3-methyl glucose distearate, polyglyceryl-3-methyl glucose distearate, polyglyceryl-10 stearate, stearic acid, potassium cetyl phosphate.
  • Such emulsifiers may be present in a total concentration of 0.1 to 3% by weight, based on the total weight of the preparation (this total concentration corresponds to the individual concentration in the case where the preparation contains only one emulsifier.
  • the second preferred embodiment of the present invention according to the invention is characterized in that the preparation is in the form of an O / W hydrodispersion stabilized with acrylate / C 10-30 alkyl acrylate crosspolymer.
  • the preparation according to the invention contains the acrylate / C 10-30
  • Alkyl acrylate crosspolymer according to the invention advantageously in a concentration of 0.05 to 1% by weight, based on the total weight of the preparation.
  • Advantageous embodiments of the present invention are characterized in that the preparation comprises one or more compounds selected from the group of the compounds ethylhexylglycerol, polyglyceryl-2-caprate, propylene glycol, butylene glycol, 2-methylpropane-1, 3-diol, 1, 2-pentanediol, 1 , 2-hexanediol, 1, 2-octanediol and / or 1, 2-decanediol.
  • Ethylhexylglycerol and butylene glycol are preferred according to the invention.
  • Such ingredients may be contained therein in a total concentration of 0.1 to 10% by weight, based on the total weight of the preparation (this total concentration corresponding to the individual concentration in the event that the preparation contains only one of these substances.
  • the preparation contains ethanol. If the preparation contains ethanol, this substance is advantageously used according to the invention in a concentration of 0.5 to 10% by weight, based on the total weight of the preparation. According to the invention, an ethanol content of 4 to 7% by weight, based on the total weight of the preparation, is preferred.
  • the preparation according to the invention may also contain phenoxyethanol.
  • the preparation is free from propyl and butyl paraben and 3-iodo-2-propynyl butylcarbamate, since even without these substances the preparation is stable to produce microbially.
  • the preparation comprises one or more active ingredients selected from the group of the compounds magnolia extract, glycyrrhetinic acid, urea, arctiin, alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, caffeine , natural and / or synthetic isoflavonoids, glyceryl glucose, hyaluronic acid, creatine, creatinine, taurine, tocopherol, tocopherol acetate, ⁇ -alanine, panthenol, aloe barbadensis and / or licochalcone A.
  • the preparation according to the invention may advantageously contain glycerol. If the preparation contains glycerol, it is advantageous according to the invention if this compound is used in a concentration of 0.1 to 20% by weight, based on the total weight of the preparation.
  • the oil phase of the preparation according to the invention contains oil, fat and wax components, for example polar oils from the group of lecithins or compounds such. B. coco glyceride, caprylic / capric acid triglyceride, olive oil, sunflower oil, jojoba oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grapeseed oil, thistle oil,
  • Tridecyl stearate Tridecyl trimellitate can be used.
  • Also advantageous according to the invention are z.
  • natural waxes of animal and vegetable origin such as beeswax and other insect waxes and berry wax, shea butter and / or lanolin (wool wax).
  • oil phase components can be advantageously selected from the group of
  • Dialkyl ethers and dialkyl carbonates are advantageous for.
  • Advantageous oil components are also z. Isopropyl palmitate, myristyl myristate,
  • Butyloctyl salicylate for example that available under the trade name Hallbrite BHB from the company CP Hall
  • tridecyl salicylate which is available under the trade name Cosmacol ESI from the company Sasol
  • C12-C15 alkyl salicylate under the trade name Dermol NS available from Alzo
  • hexadecyl benzoate and butyl octyl benzoate and mixtures thereof ⁇ Hallstar AB
  • the oil phase can also advantageously contain non-polar oils, for example those which are selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, Vaseline (petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutenes, C13- 16 isoparaffin and isohexadecane.
  • non-polar oils for example those which are selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, Vaseline (petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutenes, C13- 16 isoparaffin and isohexadecane.
  • non-polar oils for example those which are selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, Vaseline (petrolatum), paraffin oil, squalane and squal
  • the preparation according to the invention contains di-n-octyl carbonate (INCI dicaprylyl carbonates), di-n-butyl adipate (INCI dibutyl adipate) and / or butylene glycol dicaprylate / dicaprate.
  • the preparation according to the invention may contain the customary ingredients and be composed as a conventional preparation.
  • the preparation according to the invention may also contain VP / hexadecene copolymer.
  • the preparation according to the invention is in the form of a spray, it is advantageous according to the invention if the preparation according to the invention has a viscosity of 100 to 1500 mPas (measured at 25 ° C. with the Rheomat R 123 from proRheo, (measuring body 1, Art. No. 200) 0191) after 30 seconds). If the preparation is in the form of a lotion, the viscosity measured by this method is advantageously up to 5000 mPas according to the invention.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une émulsion huile dans eau cosmétique (émulsion H/E) ou une hydrodispersion comportant une phase aqueuse externe contenant de la glycine exempte de composés de zinc.
PCT/EP2015/066019 2014-08-21 2015-07-14 Préparation cosmétique stable WO2016026614A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP15739232.5A EP3182954A1 (fr) 2014-08-21 2015-07-14 Préparation cosmétique stable

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102014216602.0A DE102014216602A1 (de) 2014-08-21 2014-08-21 Stabile kosmetische Zubereitung
DE102014216602.0 2014-08-21

Publications (1)

Publication Number Publication Date
WO2016026614A1 true WO2016026614A1 (fr) 2016-02-25

Family

ID=53682676

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2015/066019 WO2016026614A1 (fr) 2014-08-21 2015-07-14 Préparation cosmétique stable

Country Status (3)

Country Link
EP (1) EP3182954A1 (fr)
DE (1) DE102014216602A1 (fr)
WO (1) WO2016026614A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3213740A1 (fr) * 2016-03-02 2017-09-06 Beiersdorf AG Produit de protection solaire contenant de la glycine
EP3093005B1 (fr) 2015-05-13 2019-03-13 Beiersdorf AG Compositions d' ecran solaire sans octocrylene comprenant diethylhexylbutamidotriazone

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016221737A1 (de) * 2016-11-07 2018-05-09 Beiersdorf Ag Creme für empfindliche Haut mit Aloe Vera und einem möglichst niedrigen Gehalt an Konservierungsmitteln
DE102017200723A1 (de) 2017-01-18 2018-07-19 Beiersdorf Ag Octocrylenfreies Sonnenschutzmittel mit Polyglyceryl-10 Stearat
DE102017204794A1 (de) 2017-03-22 2018-09-27 Beiersdorf Ag Sonnenschutzmittel mit Triacontanyl PVP
DE102017204793A1 (de) 2017-03-22 2018-09-27 Beiersdorf Ag Sonnenschutzmittel mit Polyglyceryl-10 Stearat und Polyclyceryl-2 Caprat
DE102017204792A1 (de) 2017-03-22 2018-09-27 Beiersdorf Ag Sonnenschutzmittel mit Polyglyceryl-10 Stearat und Linalool
DE102017204791A1 (de) 2017-03-22 2018-09-27 Beiersdorf Ag Sonnenschutzmittel mit Polyglyceryl-10 Stearat und Citronellol

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013518A1 (fr) 1991-02-06 1992-08-20 Beiersdorf Ag Produits cosmetiques stables
WO2003082221A1 (fr) * 2002-03-28 2003-10-09 Beiersdorf Ag Formulations cosmetiques et dermatologiques de protection solaire resistantes a l'eau contenant des polymeres sequences de polyoxyethylene-polydodecylglycol
US20050013782A1 (en) * 2001-12-20 2005-01-20 Beiersdorf Ag Cosmetic or dermatological light-protective formulation comprising a bisresorcinyl triazine derivative and a benzoxazole derivative
DE102005062097A1 (de) 2005-12-22 2007-07-05 Stada Arzneimittel Ag Lichtschutzzubereitung mit Mikropigmenten
US20100119461A1 (en) * 2007-01-23 2010-05-13 Merck Patent Gmbh Antimicrobial composition
US20110152292A1 (en) * 2008-07-03 2011-06-23 Merck Patent Gesellschaft Salts comprising a pyrimidinecarboxylic acid derivative for cosmetic use
US20130022560A1 (en) * 2009-12-09 2013-01-24 Alexander Schlifkeposchalko Novel compounds
US20130085186A1 (en) * 2006-09-19 2013-04-04 Basf Se Cosmetic preparations based on molecularly imprinted polymers
WO2014090363A1 (fr) * 2012-12-13 2014-06-19 Merck Patent Gmbh Dérivés de 3-hydroxy-4-oxo-4h-pyrane ou de 3-hydroxy-4-oxo-1,4-dihydropyridine utilisés comme substances actives adhérant aux protéines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827514B1 (fr) * 2001-07-18 2003-09-12 Oreal Composition a usage topique contenant un polymere diblocs
FR2827513B1 (fr) * 2001-07-18 2005-09-23 Oreal Composition a usage cosmetique ou dermatologique contenant un polymere triblocs
DE102012214234A1 (de) * 2012-08-10 2014-02-13 Beiersdorf Ag Kosmetische W/O–Emulsion

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013518A1 (fr) 1991-02-06 1992-08-20 Beiersdorf Ag Produits cosmetiques stables
US20050013782A1 (en) * 2001-12-20 2005-01-20 Beiersdorf Ag Cosmetic or dermatological light-protective formulation comprising a bisresorcinyl triazine derivative and a benzoxazole derivative
WO2003082221A1 (fr) * 2002-03-28 2003-10-09 Beiersdorf Ag Formulations cosmetiques et dermatologiques de protection solaire resistantes a l'eau contenant des polymeres sequences de polyoxyethylene-polydodecylglycol
DE102005062097A1 (de) 2005-12-22 2007-07-05 Stada Arzneimittel Ag Lichtschutzzubereitung mit Mikropigmenten
US20130085186A1 (en) * 2006-09-19 2013-04-04 Basf Se Cosmetic preparations based on molecularly imprinted polymers
US20100119461A1 (en) * 2007-01-23 2010-05-13 Merck Patent Gmbh Antimicrobial composition
US20110152292A1 (en) * 2008-07-03 2011-06-23 Merck Patent Gesellschaft Salts comprising a pyrimidinecarboxylic acid derivative for cosmetic use
US20130022560A1 (en) * 2009-12-09 2013-01-24 Alexander Schlifkeposchalko Novel compounds
WO2014090363A1 (fr) * 2012-12-13 2014-06-19 Merck Patent Gmbh Dérivés de 3-hydroxy-4-oxo-4h-pyrane ou de 3-hydroxy-4-oxo-1,4-dihydropyridine utilisés comme substances actives adhérant aux protéines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Velvet Milk SPF 30 - Body", MINTEL - GNPD, 1 April 2012 (2012-04-01), Inernet, pages 1 - 3, XP055214130, Retrieved from the Internet <URL:http://www.gnpd.com/sinatra/recordpage/1778099/from_search/3oWpMecmwg/> [retrieved on 20150917] *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3093005B1 (fr) 2015-05-13 2019-03-13 Beiersdorf AG Compositions d' ecran solaire sans octocrylene comprenant diethylhexylbutamidotriazone
EP3225230B1 (fr) 2015-05-13 2019-07-17 Beiersdorf AG Produit de protection contre le soleil sans octocrilène contenant du diéhulhéxylbutanidortriazone
EP3213740A1 (fr) * 2016-03-02 2017-09-06 Beiersdorf AG Produit de protection solaire contenant de la glycine

Also Published As

Publication number Publication date
EP3182954A1 (fr) 2017-06-28
DE102014216602A1 (de) 2016-02-25

Similar Documents

Publication Publication Date Title
WO2016026614A1 (fr) Préparation cosmétique stable
EP2485805B1 (fr) Préparation cosmétique contenant des cétéarylsulfosuccinates et de la trisbiphényl-triazine
EP2874912B1 (fr) Nouveau spray cosmétique solaire
WO2014012705A2 (fr) Nouveau spray cosmétique solaire
WO2015150115A1 (fr) Préparation cosmétique de protection contre les uv à base d&#39;acrylate
WO2014191197A1 (fr) Préparation cosmétique stable
EP2485806B1 (fr) Utilisation de cétéarylsulfosuccinates dans des préparations cosmétiques de protection solaire
EP3003260B1 (fr) Préparation cosmétique, contenant de la polysilicone-25 et des filtres uv solubles dans l&#39;eau présentant une fonction d&#39;acide sulfonique
EP3125860B1 (fr) Préparations cosmétiques pour la protection anti uv sur la base des copolymères d&#39;acrylate
DE102010042147A1 (de) Konservierungsmittelfreies Sonnenschutzmittel
DE202013001754U1 (de) Sonnenschutzmittel zur Anwendung auf nasser Haut
EP3125861A1 (fr) Préparation cosmétique de protection contre les uv à base d&#39;un copolymère d&#39;acrylate et d&#39;hydroxyéthylcellulose
EP2496309B1 (fr) Préparation cosmétique contenant des cétéarylsulfosuccinates ainsi que des filtres uv liquides
EP2926799B1 (fr) Préparation cosmétique pour hydratation accrue de la peau
EP2958542A1 (fr) Produit de protection solaire contenant du dialkyléther, destiné à être utilisé sur une peau humide
EP2958633A1 (fr) Produit de protection solaire contenant de l&#39;éthylméthicone
EP2468362B1 (fr) Préparation cosmétique comprenant un filtre UVA et du sulfate cétéarylique sodique
EP2451535A2 (fr) Préparation cosmétique contenant un acide glycyrrhétinique
EP3125863A1 (fr) Procédé de protection de la peau contre le rayonnement uv
DE102014219245A1 (de) Dünnflüssige kosmetische Wasser-in-Öl-Emulsion

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15739232

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2015739232

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2015739232

Country of ref document: EP